By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Abbott Molecular, Inc. 

Abbott Park

Des Plaines  Illinois  60018-3315  U.S.A.
Phone: 224-361-7000 Fax: 224-361-7008



Company News
FDA Approves Abbott Molecular, Inc. Test for Identifying Hepatitis C Genotypes 6/20/2013 12:11:30 PM
BioGenex, Inc. and Abbott Molecular, Inc. Conclude Successful Partnership 3/4/2013 10:07:05 AM
Abbott Molecular, Inc. Forms Pact With Janssen Biotech Inc. for Leukemia Test 2/21/2013 7:28:03 AM
Abbott Laboratories (ABT) and Merck & Co., Inc. (MRK) Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy 3/6/2012 10:31:23 AM
Abbott Molecular, Inc. Expands Agreement With GlaxoSmithKline (GSK) to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen 11/28/2011 7:08:02 AM
Abbott Molecular, Inc.'s Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA 10/25/2011 6:16:22 AM
China Department of Health Issues Recall for Abbott Molecular, Inc.'s Preparation System 10/14/2011 8:55:56 AM
Abbott Molecular, Inc. Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection 8/29/2011 7:01:33 AM
FDA Clears Abbott Molecular, Inc.'s Genetic FISH Panel for Leukemia Patient Prognosis 8/22/2011 6:50:49 AM
Abbott Molecular, Inc.'s Ibis Technology Identified Fatal Disease Organism in Afghanistan 2/7/2011 1:01:42 PM